ArticleRMD open2022

Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis.

Jonathan Kay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.